- Revenue growth of 16 percent to $473.1 million;
- Net income growth of 13 percent to $65.9 million; and
- Cash flow from operations of $134.7 million.
Cramer said the market is a ball of confusion and he doesn't blame any investor for sitting on the sidelines a while.
TheStreet highlights 3 stocks pushing the drugs industry lower today.
While the healthcare giant undoubtedly will be a force to reckon with in the years ahead, TeamHealth and Mednax may be in a position to benefit during the integration period.